Study of the Safety, Tolerability, and PK of PRA-027 Administered to Women of Nonchildbearing Potential
NCT00427544
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Fibroid
Interventions
DRUG:
PRA-027
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer